Wonbiogen Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
Wonbiogen has been growing earnings at an average annual rate of 95.3%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 20.9% per year. Wonbiogen's return on equity is 13.9%, and it has net margins of 15.5%.
Anahtar bilgiler
95.3%
Kazanç büyüme oranı
100.8%
EPS büyüme oranı
| Medical Equipment Sektör Büyümesi | 22.7% |
| Gelir büyüme oranı | 20.9% |
| Özkaynak getirisi | 13.9% |
| Net Marj | 15.5% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Gelir ve Gider Dağılımı
Wonbiogen nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 29,391 | 4,562 | 5,998 | 907 |
| 31 Mar 24 | 28,892 | 5,049 | 6,208 | 551 |
| 31 Dec 23 | 29,615 | 5,497 | 6,051 | 504 |
| 30 Sep 23 | 27,891 | 4,301 | 6,090 | 507 |
| 30 Jun 23 | 27,782 | 5,227 | 6,225 | 556 |
| 31 Mar 23 | 27,526 | 3,913 | 6,306 | 482 |
| 31 Dec 22 | 26,748 | 3,206 | 6,459 | 492 |
| 30 Sep 22 | 26,543 | 3,455 | 6,790 | 486 |
| 30 Jun 22 | 24,376 | 2,507 | 6,522 | 415 |
| 31 Mar 22 | 21,868 | 2,368 | 5,655 | 527 |
| 31 Dec 21 | 17,721 | -716 | 4,573 | 585 |
| 30 Sep 21 | 15,390 | -9,681 | 3,026 | 448 |
| 30 Jun 21 | 14,048 | -9,224 | 2,206 | 487 |
| 31 Mar 21 | 12,111 | -14,361 | 1,636 | 493 |
| 31 Dec 20 | 12,018 | -11,662 | 1,573 | 489 |
Kaliteli Kazançlar: A307280 has high quality earnings.
Büyüyen Kar Marjı: A307280's current net profit margins (15.5%) are lower than last year (18.8%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: A307280 has become profitable over the past 5 years, growing earnings by 95.3% per year.
Büyüme Hızlandırma: A307280's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Kazançlar vs. Sektör: A307280 had negative earnings growth (-12.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (4%).
Özkaynak Getirisi
Yüksek ROE: A307280's Return on Equity (13.9%) is considered low.